Mutational context and diverse clonal development in early and late bladder cancer.

[1]  A. Bouchard-Côté,et al.  PyClone: statistical inference of clonal population structure in cancer , 2014, Nature Methods.

[2]  Kai Wang,et al.  Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy , 2014, Modern Pathology.

[3]  Jason B. Nikas,et al.  APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma. , 2013, Cancer research.

[4]  Huanming Yang,et al.  Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation , 2013, Nature Genetics.

[5]  Benjamin J. Raphael,et al.  Mutational landscape and significance across 12 major cancer types , 2013, Nature.

[6]  A. Valencia,et al.  Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy , 2013, Nature Genetics.

[7]  M. Babjuk,et al.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. , 2013, European urology.

[8]  C. Sander,et al.  Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Steven A. Roberts,et al.  An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers , 2013, Nature Genetics.

[10]  N. A. Temiz,et al.  Evidence for APOBEC3B mutagenesis in multiple human cancers , 2013, Nature Genetics.

[11]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[12]  M. Kotler,et al.  APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion. , 2013, Cancer research.

[13]  Steven A. Roberts,et al.  Mutational heterogeneity in cancer and the search for new cancer genes , 2014 .

[14]  Steven J. M. Jones,et al.  Integrated genomic characterization of endometrial carcinoma , 2013, Nature.

[15]  K. Kinzler,et al.  Cancer Genome Landscapes , 2013, Science.

[16]  Carlos Caldas,et al.  The implications of clonal genome evolution for cancer medicine. , 2013, The New England journal of medicine.

[17]  N. A. Temiz,et al.  APOBEC3B is an enzymatic source of mutation in breast cancer , 2013, Nature.

[18]  Per-Uno Malmström,et al.  Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer. , 2013, The American journal of pathology.

[19]  S. Gabriel,et al.  Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability , 2012, Genome research.

[20]  Steven A. Roberts,et al.  Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .

[21]  I. Willner,et al.  APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repair. , 2012, Blood.

[22]  Irmtraud M. Meyer,et al.  The clonal and mutational evolution spectrum of primary triple-negative breast cancers , 2012, Nature.

[23]  A. Bashashati,et al.  Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer , 2012, Genome research.

[24]  A. Børresen-Dale,et al.  Mutational Processes Molding the Genomes of 21 Breast Cancers , 2012, Cell.

[25]  A. McKenna,et al.  Absolute quantification of somatic DNA alterations in human cancer , 2012, Nature Biotechnology.

[26]  Pablo Cingolani,et al.  © 2012 Landes Bioscience. Do not distribute. , 2022 .

[27]  Albert J. Vilella,et al.  Insights into hominid evolution from the gorilla genome sequence , 2012, Nature.

[28]  Huanming Yang,et al.  Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder , 2011, Nature Genetics.

[29]  Michael C. Rusch,et al.  CREST maps somatic structural variation in cancer genomes with base-pair resolution , 2011, Nature Methods.

[30]  Carsten Wiuf,et al.  Rseg - an R package to optimize segmentation of SNP array data , 2011, Bioinform..

[31]  J. Hoeijmakers,et al.  Involvement of Global Genome Repair, Transcription Coupled Repair, and Chromatin Remodeling in UV DNA Damage Response Changes during Development , 2010, PLoS genetics.

[32]  K. Baggerly,et al.  Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy , 2008, Laboratory Investigation.

[33]  H. Abol‐enein Infection: Is it a cause of bladder cancer? , 2008, Scandinavian journal of urology and nephrology. Supplementum.

[34]  Ziheng Yang PAML 4: phylogenetic analysis by maximum likelihood. , 2007, Molecular biology and evolution.

[35]  Mogens Kruhøffer,et al.  Gene Expression in the Urinary Bladder , 2004, Cancer Research.

[36]  P. Green,et al.  Transcription-associated mutational asymmetry in mammalian evolution , 2003, Nature Genetics.

[37]  Torben F. Ørntoft,et al.  Identifying distinct classes of bladder carcinoma using microarrays , 2003, Nature Genetics.

[38]  T. H. van der Kwast,et al.  Molecular evolution of multiple recurrent cancers of the bladder. , 2000, Human molecular genetics.